PeopleImages/iStock via Getty Images
Shares of Robert Half (NYSE:RHI) have been an extremely poor performer over the past year, losing about one-third of their value, and are back to levels last seen in 2023. The slowing labor market has been an
Robert Half: Avoid Shares After A Brutal Q1
Summary
- Shares of Robert Half have plummeted, losing a third of their value, due to a weak labor market and poor Q1 results.
- Revenue and margins are under significant pressure, with broad-based declines across segments and a particularly sharp drop in overseas performance.
- Despite a strong balance sheet and secure dividend, the company faces ongoing challenges from macroeconomic factors and internal cost bloat.
- With no clear catalyst for recovery and an expensive valuation, I remain bearish and recommend continuing to sell shares.
Over fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have a question for an article, just let me know!
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.